Saltar al contenido principal
Elsevier

Formulation of Monoclonal Antibody Therapies

From Lab to Market

  • 1 Edición - 20 de mayo de 2023
  • Última edición
  • Autor: Amal Ali Elkordy
  • Idioma: Inglés

Formulation of Monoclonal Antibody Therapies: From Lab to Market covers a wide range of topics about therapeutic monoclonal antibodies (mAbs) with a focus on formulation aspects.… Leer más

Descripción

Formulation of Monoclonal Antibody Therapies: From Lab to Market covers a wide range of topics about therapeutic monoclonal antibodies (mAbs) with a focus on formulation aspects. Therapeutic monoclonal antibodies are used for treatment of chronic diseases. It brings together a comprehensive knowledge in one accessible volume. Starting with foundational information on monoclonal antibodies, the book then discusses the importance of biopharmaceutical products, monoclonal antibodies, and biosimilars in treatment of chronic diseases, pharmaceutical aspects of mAbs, and how it can be administered. It also covers the industrial point of view and the clinical application of mAbs including in oncology, general medicine, rheumatology, hematology, dermatology, gastrointestinal tract, metabolic diseases, and dentistry. Formulation of Monoclonal Antibody Therapies: From Lab to Market is essential reading for researchers in biotechnology and biopharmaceutical fields, academics and pharmaceutical industrial scientists, and university students in pharmaceutical and biopharmaceutical sciences.

Puntos claves

  • Covers details of recent advances in using mAbs
  • Examines how to overcome the challenges for formulations of therapeutic mAbs
  • Includes clinical application of mAbs

De interès para

Researchers in biotechnology/biopharmaceutical fields, academics and pharmaceutical industrial scientists, and advanced university students in pharmaceutical and biopharmaceutical sciences

Índice

1. Introduction about monoclonal antibodies

2. Biosimilar antibodies

3. Pharmaceutical aspects of mAbs: formulation, characterization, and current route of administration of monoclonal antibody therapies

4. Route of monoclonal antibodies administration

5. Industrial aspects of finished monoclonal antibody therapies

6. Application of approved and marketed products of monoclonal antibody therapies

Detalles del producto

  • Edición: 1
  • Última edición
  • Publicado: 23 de mayo de 2023
  • Idioma: Inglés

Sobre el autor

AE

Amal Ali Elkordy

His research is on the areas of formulation of macromolecules, solid dosage forms, gene therapy, niosomal nano-particulate systems and enhancement of dissolution of poorly-water soluble drugs and has received several awards and presented work at several national and international conferences. Research outcomes are reachable to non-specialist audiences as well as to experts in the field of pharmaceutics and are recognised both nationally and internationally as evidenced from the significantly publish of over 130 publications, including journal articles and conference papers, most of which are published in high-impact journals and well-cited. Dr Elkordy has extensive teaching experience incorporating research findings as “Research informs Teaching”. He designed MSc Pharmaceutical and BioPharmaceutical Formulations which is one of the few courses in the UK covering biopharmaceuticals as well as pharmaceuticals.
Afiliaciones y experiencia
Professor of Pharmaceutics, Faculty of Health Sciences and Wellbeing, School of Pharmacy and Pharmaceutical Sciences, University of Sunderland, Sunderland, UK

Ver libro en ScienceDirect

Lee Formulation of Monoclonal Antibody Therapies en ScienceDirect